Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04330976 · ClinicalTrials.gov registry record · NA

Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC

A NA study of Gestational Weight Gain, sponsored by University of Hawaii.

Completed
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT04330976 is a NA study of Gestational Weight Gain that has completed, run by University of Hawaii. The registered enrollment target is 83 participants, below the 481-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04330976, a NA study of Gestational Weight Gain, has completed, sponsored by University of Hawaii.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The objective of this trial was to investigate the effect of educational short message service (SMS), or text messages, on gestational weight gain (GWG) in a low-income population.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Nutrition and physical activity intervention

Study Locations (1)

Hawaii

  • University of Hawaii - Honolulu

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2017-10-30
Est. Completion 2019-06-02
Phase NA

Sponsor

University of Hawaii

77 total trials

What the Registry Record Tells You About NCT04330976

The ClinicalTrials.gov registry entry for NCT04330976 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (83% lower). The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT04330976 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.

Frequently Asked Questions

What is clinical trial NCT04330976 about?

NCT04330976 is a clinical study titled "Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC". The objective of this trial was to investigate the effect of educational short message service (SMS), or text messages, on gestational weight gain (GWG) in a low-income population.

What is the current status of trial NCT04330976?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2017-10-30. Estimated completion is 2019-06-02.

What conditions does trial NCT04330976 study?

This clinical trial studies the following conditions: Gestational Weight Gain.

What interventions are being tested in trial NCT04330976?

The interventions under investigation include: Control (BEHAVIORAL), Nutrition and physical activity intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04330976?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04330976 being conducted?

This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Weight Gain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.